biomarker

Related by string. Biomarker * * biomarker discovery . biomarker assays . biomarker validation . protein biomarker . Biomarker Discovery . imaging biomarker . predictive biomarker . biomarker identification . biomarker assay development . protein biomarker discovery . diagnostic biomarker . BioMarker Strategies . biomarker assay . biomarker discovery soil . molecular biomarker *

Related by context. All words. (Click for frequent words.) 87 biomarkers 75 protein biomarkers 70 molecular biomarkers 69 gene expression profiling 69 protein biomarker 69 prognostic marker 69 biomarker discovery 68 genetic biomarkers 67 diagnostic biomarker 67 predictive biomarker 67 predictive biomarkers 66 diagnostic biomarkers 66 microRNA 66 microRNA biomarkers 66 gene expression 65 molecular markers 65 miRNA 65 prognostic 65 clusterin 65 microarray 65 galectin 3 65 molecular profiling 65 prognostic markers 64 pharmacogenetic 64 genomic 64 vivo 64 Biomarker 64 proteomic 64 microRNA expression 64 PITX2 64 metabolomics 64 single nucleotide polymorphism 64 companion diagnostics 64 molecular biomarker 63 genotyping 63 microRNA profiling 63 kinase profiling 63 metabolomic 63 HAAH 63 gene amplification 63 genomewide 63 peptide BNP 63 Corus CAD 63 miRNA expression 62 biomarker assay 62 KRAS mutation 62 NGAL 62 serum biomarkers 62 genetic markers 62 eTag assays 62 endoglin 62 immunohistochemical 62 genetic polymorphisms 62 Lp PLA2 62 prognostic biomarker 62 miRNAs 62 prognostic indicator 62 PET imaging 62 therapeutics 62 genomic biomarkers 62 serum protein biomarkers 62 biochemical marker 61 Epigenomics proprietary 61 ADME Tox 61 methylated DNA 61 miRNA biomarkers 61 pharmacogenetic testing 61 quantitative PCR 61 p# INK4a 61 DNA methylation biomarker 61 methylation markers 61 FDG PET 61 toxicogenomics 61 kinase inhibitors 61 biomarker assays 61 metabolite identification 61 DNA methylation biomarkers 61 PARP inhibition 61 P#X# 61 tumor hypoxia 61 small molecule activators 61 HERmark 61 microRNAs 61 Clusterin 61 TLE3 61 MammaPrint R 61 therapeutic monoclonal antibody 60 diagnose Alzheimer disease 60 splice variant 60 vitro assay 60 biomarker identification 60 risk stratification 60 Biomarkers 60 immunochemical 60 MicroRNA 60 proteomics 60 molecular diagnostic 60 endophenotypes 60 metabolomic profiling 60 KineMed 60 PCA3 60 VKORC1 60 somatic mutations 60 Lp PLA 2 60 A3 adenosine receptor 60 PKCi 60 atherosclerosis regression 60 antibody 60 diagnostic prognostic 60 promoter methylation 60 SNP rs# [001] 60 molecular diagnostic tests 60 ELISpot 60 lipid 60 serine protease 60 VEGF receptor 60 micro RNA 60 diagnostic assays 60 qRT PCR 60 cystatin C 60 PSP# [002] 59 cardiac troponin 59 biochemical markers 59 immunohistochemical staining 59 PD2i ® 59 stratify patients 59 SNP genotyping 59 Septin 9 59 NPM1 59 genetic variants 59 breast cancer subtypes 59 prognostic biomarkers 59 monoclonal antibodies 59 theranostic 59 Septin9 59 vimentin 59 small molecule inhibitors 59 validate biomarkers 59 gene expression profiles 59 quantitative gene expression 59 breast cancer metastasis 59 surrogate marker 59 Mammostrat 59 TLR9 agonists 59 serum biomarker 59 QPCR 59 immunoregulatory 59 genomic alterations 59 ChemoFx ® 59 S#A# [002] 59 Azedra 59 microarray analysis 59 JAK3 59 preclinical 59 PI3K inhibitors 59 sDNA 59 BioMAP 59 sarcosine 59 pharmacogenetics 59 NT proBNP 59 DNA methylation 59 GAP #B# 59 kinase inhibition 59 RECAF 59 KRAS mutation status 59 quantitative PCR qPCR 59 RT qPCR 59 CellCiphr 59 selective inhibition 59 GSTP1 59 PCA3 gene 59 multi analyte 59 immunohistochemistry IHC 59 Her2/neu 59 cerebrospinal fluid CSF 59 DNA methylation patterns 59 DNA methyltransferases 59 natriuretic peptide 59 transcriptomic 59 soluble CD# ligand 59 β amyloid 59 WT1 59 CCR3 59 miRview TM mets 59 molecular assays 59 putative biomarkers 59 splice variants 59 personalized medicine 59 UGT#A# 59 druggable target 59 FLT3 59 chemoprevention 59 stratifying patients 58 disease modifying 58 HIF PH inhibitors 58 chemokine receptor 58 pharmacogenetic tests 58 VeriStrat 58 HER2 overexpression 58 IGF IR 58 gene polymorphisms 58 NSCLC tumors 58 SiMoA 58 DNA methylation markers 58 anti fibrotic 58 Chronix 58 myeloperoxidase 58 clinically validated 58 carcinoembryonic antigen 58 prostate cancer PCa 58 p#INK#a 58 microRNA miRNA 58 surrogate markers 58 multiplex assay 58 platelet function 58 proteomic analysis 58 EpCAM 58 SNPs 58 BRAF mutation 58 preclinically 58 siRNA therapeutics 58 RNAi therapeutic targeting 58 Wnt signaling pathway 58 gefitinib Iressa 58 K ras 58 chemosensitivity 58 diagnostic 58 anticancer therapeutics 58 Smurf1 58 genomic proteomic 58 telomerase activation 58 B7 H3 58 biologic pathways 58 HER3 58 druggable targets 58 FISH fluorescence 58 Molecular imaging 58 novel peptide 58 engineered RAP peptides 58 PITX2 methylation 58 gene fusions 58 metabolite profiling 58 CDK inhibitors 58 pharmacogenetic test 58 polymorphisms 58 midkine 58 autoantibody 58 glycan structures 58 biomarker validation 58 multiplex immunoassay 58 Hsp# inhibition 58 ptau 58 transcriptional regulation 58 biochemical profiling 58 prostate cancer CaP 58 miRview mets 58 transgenic mouse models 58 IFRD1 58 EGFR HER 58 peptide 58 PCR assay 58 methylation patterns 58 comparative genomic hybridization 58 miR #a [002] 58 situ hybridization 58 PIK3CA 57 ANGPTL4 57 T#I [002] 57 small molecule 57 SmartChip System 57 CCR1 57 whole genome genotyping 57 Mass spectrometry 57 prognostic significance 57 presymptomatic 57 tumor biopsies 57 ErbB3 57 Prognostic 57 cytokine 57 Aurora kinase 57 MSMB 57 prognostic indicators 57 genomic biomarker 57 multigene 57 pretargeting 57 array CGH 57 Haptoglobin 57 causative genes 57 AtherOx 57 Trofex 57 T SPOT.TB 57 IGF 1R 57 neutrophil gelatinase associated lipocalin 57 MAbs 57 genetic variants associated 57 genetic variations 57 kinase 57 MAPK pathway 57 RNase L 57 methylation 57 DNA microarray 57 myeloproliferative disorders 57 p# biomarker 57 pharmacogenomics 57 kinase assay 57 deacetylase 57 ALN TTR 57 myelofibrosis polycythemia vera 57 KineMarker TM 57 FGFR3 57 quantitative RT PCR 57 APTIMA HPV 57 immunohistochemistry 57 molecular diagnostic assays 57 human leukocyte antigen 57 Anticalins ® 57 flavopiridol 57 RECAF TM 57 secretory phospholipase A2 sPLA2 57 PROLARIS 57 Getzenberg 57 molecular imaging 57 pharmacological chaperone 57 KinomeScan 57 microarrays 57 tumor suppressor protein 57 multiplexed assays 57 multiplex PCR 57 quantitative proteomics 57 rBChE 57 NPRL2 57 cell lysate 57 chemopreventive agent 57 histone deacetylases 57 molecular pathology 57 epigenetic therapies 57 histone modifications 57 Flow cytometry 57 AclarusDx ™ 57 proteomic biomarkers 57 activin 57 JAK2 inhibitors 57 CyPath ® assay 57 lentiviral 57 OGG1 57 human hepatocytes 57 immunoassay 57 biomolecular interactions 57 hERG 57 skin sterol 57 PTEN gene 57 LungExpress Dx TM 57 MammaPrint 57 nonclinical studies 57 miRNA molecules 57 Syk 57 HemeScan test 57 miRview ™ squamous 57 Mutation Analysis 57 Stat5 57 mass spectrometry 57 ELISA assay 57 NanoString 57 sPLA2 57 Western blotting 57 tranilast 57 microsatellite instability 57 osteopontin 57 Protein Kinase C 57 Osteopontin 57 endothelial activation 57 toxicogenomic 57 therapeutic monoclonal antibodies 57 anti CD3 57 NuroPro ® 57 bioluminescent imaging 57 Hedgehog pathway 56 siRNA therapeutic 56 thrombin receptor 56 PPARγ 56 nCounter 56 Cdc7 56 MEK inhibitors 56 antisense oligonucleotides 56 MGd 56 pharmacologic intervention 56 HepDirect prodrug 56 A2 Lp PLA2 56 SERMs 56 isotypes 56 JAK2 inhibitor 56 TNFa 56 IDH1 56 aggregated Abeta 56 pro angiogenic 56 susceptibility gene 56 plasma kallikrein 56 HER1 56 PKM2 56 TPMT 56 resolvins 56 pharmacodynamic PD 56 bispecific antibody 56 sphingolipid 56 miR #a [001] 56 BCR ABL 56 stem cell therapeutics 56 gene expression patterns 56 cellular pathways 56 K RAS 56 noninvasive imaging 56 oxysterols 56 Hedgehog inhibitor 56 Tr DNA 56 investigational therapies 56 Affymetrix microarray technology 56 haematopoietic 56 hypermethylation 56 Cyclin E 56 liver fibrosis 56 monoclonal 56 PARP inhibitors 56 cTnI 56 Oncotype DX colon cancer 56 uPA 56 antiangiogenic agent 56 FGFR 56 gene expression assays 56 virulence genes 56 molecular diagnostics 56 molecular subtypes 56 protein kinase C 56 protein misfolding 56 non coding RNA 56 Galectin 3 56 rs# [002] 56 gene variants 56 thyroid stimulating hormone 56 hypermethylated 56 multiplex assays 56 LungExpress Dx 56 GFT# 56 nCounter Analysis System 56 molecular chaperone 56 PI3K AKT 56 microarray experiments 56 Onconase 56 cytogenetic 56 ZNF# 56 NPM1 mutation 56 kinase assays 56 cell signaling pathways 56 humanised antibody 56 BiTE 56 apolipoproteins 56 selective inhibitors 56 perfusion CT 56 genetic determinants 56 K ras mutations 56 biologic therapeutics 56 microdeletions 56 pharmacodynamic biomarkers 56 Prostate Px + 56 vascular disrupting agents 56 JAK2 56 TCF#L# 56 florbetaben 56 Anticalin ® 56 Six3 56 delipidation 56 cathepsin K 56 gene expression microarrays 56 anti JCV antibodies 56 uPAR 56 surrogate endpoint 56 menstrual stem cell 56 EGFR 56 GRP# 56 IL#B 56 HERmark assay 56 pharmacogenomic 56 Tyrima 56 haplotyping 56 mAb 56 Eg5 56 cytokeratin 56 RNA seq 56 throughput RNAi 56 neuroregenerative 56 5 hydroxymethylcytosine 56 molecularly targeted 56 noncoding RNAs 56 beta1 integrin 56 EGFR mutations 56 B7 H4 56 quantitate 56 Microarray 56 CEQ# 56 GPCR targets 56 molecular abnormalities 56 differentially expressed proteins 56 metabolic profiling 56 NMP# 56 independent prognostic marker 56 susceptibility genes 56 Immunohistochemical staining 56 Fc gamma receptor 56 mutational analysis 56 biologic 56 mGlu2 3 56 epithelial tumors 56 targeted radiotherapeutic 56 ADAM# 56 kinases 56 D Dimer 56 cardiac troponin T 56 therapeutic peptide 56 salivary diagnostics 56 Posiphen 56 glycosylated 56 gene locus 56 immunomodulation 56 situ hybridisation 56 serologic 56 Reverse Cholesterol Transport 56 positron emission tomography PET 56 amyloid imaging 56 small molecule agonists 56 micro RNAs 56 predictive toxicology 56 protein tyrosine phosphatase 56 RQ PCR 56 cancer therapeutics 56 epigenetic markers 56 Immunohistochemistry 56 genetic loci 56 COLD PCR 56 delta isoform 56 ENMD # 56 STK# [002] 56 miRNA profiling 56 tumorigenicity 56 Affymetrix GeneChip 56 thyroglobulin 56 KRAS 56 transfection reagents 56 CYT# potent vascular disrupting 55 PCa 55 PLAC test 55 nanomolar 55 metabolic enzymes 55 platelet activation 55 xCELLigence System 55 magnetic resonance spectroscopy MRS 55 CDK inhibitor 55 ADME properties 55 PD2i R 55 ChIP chip 55 miR #b [002] 55 malignant nodules 55 HDACs 55 isoform selective 55 DNA microarrays 55 prognostic factor 55 Gene Expression Assays 55 ALK inhibitors 55 tubulin inhibitor 55 5 hmC 55 GRK2 55 potent inhibitors 55 enzastaurin 55 p# MAPK 55 oligonucleotide therapeutics 55 RBP4 55 qPCR 55 iPSC 55 MTHFR 55 TLR3 55 gene loci 55 VEGF expression 55 Annexin V 55 flow cytometry 55 Oncotype 55 Quanterix 55 Cystatin C 55 #F FDG PET 55 affinity purification 55 p# inhibitors 55 prostate carcinoma 55 protein biochip 55 genomic profiling 55 N Myc 55 FDDNP 55 aCGH 55 pathophysiological 55 tyrosine phosphorylation 55 biodistribution 55 underlying molecular mechanisms 55 IL #R 55 TSP1 55 CD# ligand 55 ADME 55 microalbuminuria 55 molecular diagnostic assay 55 Curaxin 55 RRM1 55 Prodarsan ® 55 mTOR inhibitors 55 substrate specificity 55 apoE 55 PGx 55 MMP# 55 SPINK1 55 Epidermal Growth Factor Receptor 55 adipogenic 55 p tau 55 PICALM 55 tissue fibrosis 55 D dimer 55 bisulfite sequencing 55 renin inhibitors 55 antithrombotic 55 immunofluorescent 55 IGFBP2 55 EGFR tyrosine kinase inhibitors 55 protein kinases 55 kidney urologic 55 Aplidin 55 pDCs 55 mechanistic insights 55 M2 subunit 55 EarlyCDT Lung 55 clinically relevant 55 VerifyNow P#Y# 55 PDGF receptor 55 germline mutations 55 GPCR 55 neuronal nicotinic receptors NNRs 55 molecular 55 theranostics 55 ERCC1 55 DNMT1 55 vivo potency 55 VeraTag assays 55 HER2 expression 55 eIF 4E 55 autoantigen 55 c MYC 55 immunotherapeutics 55 miRview ™ mets 55 optimal dosing regimens 55 NS5A 55 Zemiva 55 P2V TM 55 immunohistochemical analysis 55 Zolinza 55 PI3K 55 antitumoral 55 FGFR2 55 Notch1 55 pharmacodynamic effects 55 mtDNA mutations 55 HDAC6 55 Symadex 55 histone deacetylase HDAC inhibitor 55 ImmuKnow 55 autism susceptibility genes 55 radiolabeled 55 FGFR1 55 genomic sequencing 55 hepatocellular carcinoma 55 thymidylate synthase TS 55 beta secretase inhibitors 55 lipid metabolites 55 Brd4 55 Circulating Tumor Cells 55 CellPort Technologies 55 therapeutically relevant 55 B type natriuretic 55 Xanafide 55 tumor subtypes 55 PTPN# 55 PathFinderTG 55 synthetic peptides 55 p# mutations 55 LRP5 55 gastric carcinoma 55 CISH 55 ZFP TF 55 ChIP seq 55 ChIP Seq 55 ParAllele 55 AEG# 55 PET tracers 55 PI3K delta 55 PCA3 prostate cancer 55 BrachySil TM 55 Bryostatin 55 IgG antibodies 55 GPx 55 cystatin 55 EphA2 55 mRNA expression 55 ADAMTS# 55 Proteomic 55 Janus Kinase 55 Sanger sequencing 55 mGluR2 NAM 55 RIP1 kinase 55 Li Fraumeni 55 autoantibodies 55 rxRNA 55 Spiegelmers 55 FUS1 55 OnDose TM 55 cell adhesion molecule 55 genotyping assays 55 antibody arrays 55 vorinostat 55 EGFR inhibition 55 FDG-PET/CT 55 histone deacetylase inhibitor 55 humanized monoclonal antibodies 55 aberrant methylation 55 urine dipstick 55 TMEM#B 55 neurodegenerative diseases 55 molecular pathogenesis 55 SCD1 55 cytotoxicity assays 55 induced sputum 55 G Protein Coupled 55 generation sequencing 55 radiotracers 55 iNOS 55 protein albumin 55 histone deacetylase HDAC 55 ATL# [001] 55 susceptibility loci 55 diagnostic modality 55 sCJD 55 E#F# 55 CBLC# 55 proton MR spectroscopy 55 plasma renin activity 55 reagent kit 55 rNAPc2 55 cAMP signaling 55 Pharmacogenomic 55 iPS derived 55 vitro ADME 55 Genetic variations 55 transcriptomics 55 retaspimycin 55 anti CD# antibodies 55 Microarrays 55 pharmacogenomic tests 55 JAK1 55 Gene Expression 55 Squalamine 55 imaging modality 55 proteome 55 Syllego system 55 AT1R 55 troponin 55 Locked Nucleic Acid LNA 55 receptor antagonists 55 xCELLigence 55 Affymetrix GeneChip ® 55 phosphorylated tau 55 VerifyNow 55 antithrombotic agents 55 Cytochrome P# 55 RNA amplification 55 Immunoassays 55 VE cadherin 55 polycythemia vera PV 55 MetAP2 55 VeraTag 55 nicotinic receptor 55 hedgehog signaling 55 kinase pathway 55 proteins 55 MAPCs 55 NMR LipoProfile test 55 apoB 55 effector function 55 inflammatory biomarkers 55 histone deacetylase HDAC inhibitors 55 IgM antibody 55 biochip 55 PALB2 55 HDAC 55 PlGF 55 MUC1 * 55 antiplatelet therapies 55 TIMP 1 55 pharmacodynamic 55 Proteomics 54 KRAS variant 54 microRNA sequences 54 Nanobodies 54 genotypic 54 lactate dehydrogenase LDH 54 antisense inhibitor 54 neuroprotection 54 CCX# 54 immunoregulation 54 novel peptides 54 CTAP# Capsules 54 ligand binding 54 LNPs 54 specific antigen 54 SLC#A# [002] 54 chromosome #p#.# 54 Psynova 54 PEDF 54 phosphorylated proteins 54 p# activation 54 LSD1 54 vivo validation 54 C. pneumoniae 54 Anticalin R 54 epothilone 54 CRAC channel 54 indibulin 54 pre malignant lesions 54 murine model 54 hepatocyte 54 XmAb# 54 SensoLyte ™ 54 IRX 2 54 protein CETP 54 peptide therapeutics 54 BRAF mutations 54 nicotinic alpha 7 54 EGFR signaling 54 viral tropism 54 endostatin 54 GPR# [002] 54 exome sequencing 54 tandem mass spectrometry 54 DNA Methylation 54 ion channel 54 GPC3 54 galectin 54 KLF4 54 HDAC inhibitors 54 ReN# 54 phenotypes 54 Cardiotoxicity 54 biological pathways 54 diabetic nephropathy 54 KRAS mutations 54 optical biosensors 54 ESBA# 54 evolutionarily conserved 54 microarray gene expression 54 depsipeptide 54 Trophos 54 formalin fixed paraffin embedded 54 perilipin 54 p# inhibitor 54 MiCK assay 54 hypoxic tumors 54 Factor VIIa 54 Theranostics 54 Nedd4 54 PLX cells 54 shRNA libraries 54 PROfusion 54 synthetic retinoid 54 cytogenetics 54 intranasal delivery 54 lipoxygenase 54 perfusion imaging 54 TÎ ² 4 54 Campath alemtuzumab 54 essential thrombocythemia 54 Biophysical Corporation 54 Darapladib 54 HER-2/neu protein 54 peptide antigens 54 antitumor 54 SPC# [001] 54 neuroprotective properties 54 Ki# 54 HeliScope Sequencer 54 Stapled Peptide 54 assay detects 54 EGFR TKIs 54 N glycan 54 kallikrein 54 pathological hallmark 54 glycan 54 antagomirs 54 ncRNA 54 hypoxia inducible factor 54 IL 1ß 54 HOXB# 54 linkage disequilibrium 54 CSF biomarkers 54 olaparib 54 humanized antibody 54 molecular pathway 54 ColoMarker 54 OncotypeDX 54 JAK inhibitors 54 cardioprotective effects 54 induces apoptosis 54 chromatin immunoprecipitation 54 JAK inhibitor 54 SGLT2 inhibitors 54 SNP Array #.# 54 TNFalpha 54 miRNA expression profiles 54 hedgehog signaling pathway 54 annexin V 54 HDAC inhibition 54 cDNA microarray 54 CA9 SCAN 54 pharmacodynamic markers 54 hematopoietic cells 54 iTRAQ 54 telomerase inhibitor 54 cardiac biomarkers 54 DCVax 54 Enzastaurin 54 protein biomarker discovery 54 metabolomic profiles 54 glycoproteins 54 antisense drugs 54 KIAA# 54 #beta HSD1 54 MetaChip 54 peptides 54 flow cytometric 54 immunoglobulin genes 54 subclinical atherosclerosis 54 PGDH 54 antibodies 54 noninvasive diagnostic 54 MAb 54 OVA1 54 miRs 54 activating mutation 54 p# biomarkers 54 RUNX3 54 Chinnaiyan 54 RNAi 54 homodimers 54 RayBiotech 54 therapeutic radiopharmaceuticals 54 Liposomal 54 SurroMed 54 DIGE 54 differentially expressed genes 54 EML4 ALK 54 TGFBR1 * 6A 54 Treg cell 54 genomewide association studies 54 tumor suppressor gene 54 ERK signaling 54 splice junctions 54 product ColonSentry TM 54 electrocardiography ECG 54 molecular determinants 54 CyPath ® 54 antigen PSA 54 γ secretase 54 S. maltophilia 54 proteoglycan 54 p# mitogen activated 54 Azacitidine 54 TTR gene 54 vidofludimus 54 immunoglobulin G 54 MIF protein 54 lipoprotein associated phospholipase 54 immunochemical fecal occult 54 GKAs 54 analytes 54 SIRT1 gene 54 neuroprotective 54 metabolomics driven 54 immunotoxin 54 siRNA 54 antibody therapeutics 54 scintigraphic 54 antisense oligonucleotide 54 phenotype 54 BACcel 54 causal variants 54 rhIGFBP 3 54 CXCR4 receptor 54 heparanase 54 Oligonucleotide 54 DiaGenic 54 secretory pathway

Back to home page